Acorda: 3Q Earnings Snapshot

November 4, 2019 GMT

ARDSLEY, N.Y. (AP) _ Acorda Therapeutics Inc. (ACOR) on Monday reported a loss of $263.5 million in its third quarter.

The Ardsley, New York-based company said it had a loss of $5.55 per share. Losses, adjusted for one-time gains and costs, were 46 cents per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.

The drugmaker posted revenue of $47.7 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $44.4 million.

In the final minutes of trading on Monday, the company’s shares hit $2. A year ago, they were trading at $19.46.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACOR at https://www.zacks.com/ap/ACOR